OBJECTIVE	This study was an open label , randomized Phase 3 trial in newly diagnosed patients with anaplastic glioma comparing radiotherapy plus adjuvant procarbazine , CCNU , and vincristine ( PCV ) chemotherapy with or without bromodeoxyuridine ( BUdR ) given as a 96-hour infusion each week of radiotherapy .\